Rat models of dementia based on reductions in regional glucose metabolism, cerebral blood flow and cytochrome oxidase activity

Journal of Neural Transmission

Volumn 111, Issue 3, 2004, Pages 347-366

  Weinstock, M ^a   Shoham, S ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HERZOG HOSPITAL   (Israel)

Author keywords

Bilateral carotid occlusion; Cerebral blood flow; Cerebral glucose metabolism; Cytochrome oxidase; Streptozotocin

Indexed keywords

AMYLOID BETA PROTEIN; ANTIOXIDANT; CHOLINESTERASE INHIBITOR; CYTOCHROME C OXIDASE; ESTRADIOL; HUPERAZINE; LADOSTIGIL; LEVACECARNINE; MELATONIN; MITOCHONDRIAL ENZYME; N PROPARGYLAMINOINDAN 5 YLETHYLCARBAMATE; NEUROPROTECTIVE AGENT; RESVERATROL; SODIUM AZIDE; STREPTOZOCIN; TACRINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BRAIN BLOOD FLOW; BRAIN MITOCHONDRION; BRAIN PERFUSION; CAROTID ARTERY LIGATION; CAROTID ARTERY OBSTRUCTION; CELL ACTIVATION; DRUG EFFECT; ENZYME ACTIVITY; GLUCOSE METABOLISM; HIPPOCAMPUS; HISTOPATHOLOGY; LEARNING DISORDER; MEMORY DISORDER; MICROGLIA; NERVE DEGENERATION; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; SEPTUM PELLUCIDUM;

ANIMALS; BRAIN ISCHEMIA; CAROTID ARTERIES; CEREBROVASCULAR CIRCULATION; DEMENTIA; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; ELECTRON TRANSPORT COMPLEX IV; GLUCOSE; LIGATION; RATS; SODIUM AZIDE;

EID: 1542343843     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-003-0058-y     Document Type: Review

References (94)

1. Aragno M, Tamagno E, Gatto V, Brignardello E, Parola S, Danni O, Boccuzzi G (1999) Dehydroepiandrosterone protects tissues of streptozotocin-treated rats against oxidative stress. Free Rad Biol Med 11: 1467-1474
2. Arnaiz E, Jelic V, Almkvist O, Wahlund LO, Winblad B, Valind S, Nordberg A (2001) Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport 12: 851-855
3. Bastar I, Seckin S, Uysal M, Aykac-Toker G (1998) Effect of streptozotocin on glutathione and lipid peroxide levels in various tissues of rats. Res Comm Mol Pathol Pharmacol 102: 265-272
4. Bennett MC, Diamond DM, Stryker SL, Parks JK, Parker WD Jr (1992) Cytochrome oxidase inhibition: a novel animal model of Alzheimer's disease. J Geriatr Psychiatry Neurol 5: 93-101
5. Bennett MC, Mlady GW, Kwon Y-H, Rose GM (1996a) Chronic in vivo sodium azide infusion induces selective and stable inhibition of cytochrome c oxidase. J Neurochem 66: 2606-2611
6. Bennett MC, Mlady GW, Fleshner M, Rose GM (1996b) Synergy between chronic corticosterone and sodium azide treatments in producing a spatial learning deficit and inhibiting cytochrome oxidase activity. Proc Natl Acad Sci USA 93: 1330-1334
7. Bennett SAL, Pappas BA, Stevens WD, Davidson CM, Fortin T, Chen J (2000) Cleavage of amyloid precursor protein elicited by chronic cerebral hypoperfusion. Neurobiol Aging 21: 207-214
8. Blokland A, Jolles J (1993) Spatial learning deficit and reduced hippocampal ChAT activity in rats after an ICV injection of streptozotocin. Pharmacol Biochem Behav 44: 491-494
9. Bonavita E (1986) Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain. Int J Clin Pharmacol Ther Toxicol 24: 511-516
10. Braak H, Del Tredici K, Schultz C, Braak E (2000) Vulnerability of select neuronal types to Alzheimer's disease. Ann NY Acad Sci 924: 53-61
11. Carter J, Lippa CF (2001) Beta-amyloid, neuronal death and Alzheimer's disease. Curr Mol Med 1: 733-737
12. Chanvitayapongs S, Draczynska-Lusiak B, Sun AY (1997) Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells. Neuroreport 8: 1499-1502
13. Chen Y, Shohami E, Constantini S, Weinstock M (1998) Rivastigmine, a brain-selective acetylcholinesterase inhibitor, ameliorates cognitive and motor deficits induced by closed-head injury in the mouse. J Neurotrauma 15: 231-237
14. Cholerton B, Gleason CE, Baker LD, Asthana S (2002) Estrogen and Alzheimer's disease: the story so far. Drugs Aging 19: 405-427
15. Colton CA, Gilbert DL (1993) Microglia, an in vivo source of reactive oxygen species in the brain. Adv Neurol 59: 321-326
16. De la Torre JC, Stefano GB (2000) Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide. Brain Res Rev 34: 119-136
17. De la Torre JC, Fortin T, Park GA, Butler KS, Kozlowski P, Pappas BA, de Socarraz H, Saunders JK, Richard MT (1992) Chronic cerebrovascular insufficiency induces dementia-like deficits in aged rats. Brain Res 582: 186-195
18. De la Torre JC, Fortin T, Park GA, Pappas BA, Richard MT (1993) Brain blood flow restoration 'rescues' chronically damaged rat CA1 neurons. Brain Res 623: 6-15
19. De la Torre JC, Cada A, Nelson N, Davis G, Sutherland RJ, Gonzalez-Lima F (1997) Reduced cytochrome oxidase and memory dysfunction after chronic brain ischemia in aged rats. Neurosci Lett 223: 165-168
20. De Leon MJ, Harris SH, George AE, Reisberg B, Christman DR, Kricheff II, Wolf AP (1983) Computed tomography and positron emission transaxial tomography evaluation of normal aging and Alzheimer's disease. J Cereb Blood Flow Metab 3: 391-394
21. Duffy PE, Rapport M, Graf L (1980) Glial fibrillary acidic protein and Alzheimer-type senile dementia. Neurology 30: 778-782
22. Folli F, Bonfanti L, Renard E, Kahn CR, Merighi A (1994) Insulin receptor substrate-1 (IRS-1) distribution in the rat central nervous system. J Neurosci 14: 6412-6422
23. Frölich F, Blum-Degen D, Hoyer S, Beckmann H, Riederer P (1998) Insulin, insulin receptors, and Igf-I receptors in post-mortem human brain in Alzheimer's disease. In: Fisher A, Hanin I, Yoshida M (eds) Progress in Alzheimer's and Parkinson's diseases. Plenum Press, New York London, pp 287-293
24. Galani R, Obis S, Coutureau E, Jarrard L, Cassel JCA (2002) Comparison of the effects of fimbria-fornix, hippocampal, or entorhinal cortex lesions on spatial reference and working memory in rats: short versus long postsurgical recovery period. Neurobiol Learn Mem 77: 1-16
25. Gibbs R, Aggarwal P (1998) Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimer's disease-related cognitive decline. Horm Behav 34: 98-111
26. Gibson GE, Blass JP (1976) Impaired synthesis of acetylcholine in brain accompanying mild hypoxia and hypoglycaemia. J Neurochem 27: 37-42
27. Gotz J, Chen F, van Dorpe J, Nitsch RM (2001) Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils. Science 293: 1491-1495
28. Grammas P (2000) A damaged microcirculation contributes to neuronal cell death in Alzheimer's disease. Neurobiol Aging 21: 199-205
29. Hagg T, Fass-Holmes B, Vahlsing HL, Manthorpe M, Conner JM, Varon S (1989) Nerve growth factor (NGF) reverses axotomy-induced decreases in choline acetyltransferase, NGF receptor and size of medial septum cholinergic neurons. Brain Res 505: 29-38
30. Harrell LE, Davis JN (1985) Cholinergic influences on hippocampal glucose metabolism. Neuroscience 15: 359-369
31. Hellweg R, Nitsch R, Hock C, Jaksch M, Hoyer S (1992) Nerve growth factor and choline acetyltransferase activity levels in the rat brain following experimental impairment of cerebral glucose and energy metabolism. J Neurosci Res 31: 479-486
32. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Petersen RB, Perry G, Smith MA (2001) Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21: 3017-3023
33. Hollerbach EH, Haas CA, Hildebrandt H, Frotscher M, Naumann T (1998) Region-specific activation of microglial cells in the rat septal complex following fimbria-fornix transection. J Comp Neurol 390: 481-496
34. Horwood N, Davies DC (1994) Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease. Virchows Arch 425: 69-72
35. Hoyer S (1990) Brain glucose and energy metabolism during normal aging. Aging 2: 245-258
36. Hoyer S (1993) Intermediary metabolism disturbance in AD/SDAT and its relation to molecular events. Prog Neuropsychopharmacol Biol Psychiatry 17: 199-228
37. Hoyer S, Hennenberg N, Knapp S, Lannert H, Martin E (1996) Brain glucose metabolism is controlled by amplification and desensitization of the neuronal insulin receptor. Ann NY Acad Sci 777: 374-379
38. Huang W, Chen Y, Shohami E, Weinstock M (1999) Neuroprotective effect of rasagiline, a selective MAO-B inhibitor, against closed head injury in the mouse. Eur J Pharmacol 366: 127-135
39. Jellinger KA (2002) Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm 109: 813-836
40. Kalaria RN, Harik SI (1992) Carnitine acetyltransferase activity in the human brain and its microvessels is decreased in Alzheimer's disease. Ann Neurol 32: 583-586
41. Kish SJ, Bergeron C, Rajput A, Dozic S, Mastrogiacomo F, Chang LJ, Wilson JM, DiStefano LM, Nobrega JN (1992) Brain cytochrome oxidase in Alzheimer's disease. J Neurochem 59: 776-779
42. Kiyosawa M, Baron JC, Hamel E, Pappata S, Duverger D, Riche D, Mazoyer B, Naquet R, MacKenzie ET (1989) Time course of effects of unilateral lesions of the nucleus basalis of Meynert on glucose utilization by the cerebral cortex. Positron tomography in baboons. Brain 112: 435-455
43. Konrad RJ, Mikolaenko I, Tolar JF, Liu K, Kudlow JE (2001) The potential mechanism of the diabetogenic action of streptozotocin: inhibition of pancreatic beta-cell O-G1cNAc-selective N-acetyl-beta-D-glucosaminidase. Biochem J 356: 31-41
44. Lannert H, Hoyer S (1998) Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci 112: 1199-1208
45. Lannert H, Wirtz P, Schuhmann V, Galmbacher R (1998) Effects of estradiol (-17beta) on learning, memory and cerebral energy metabolism in male rats after intracerebroventricular administration of streptozotocin. J Neural Transm 105: 1045-1063
46. Li X, Schwartz PE, Rissman EF (1997) Distribution of estrogen receptor-beta-like immunoreactivity in rat forebrain. Neuroendocrinol 66: 63-67
47. Luine VN (1985) Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 89: 484-490
48. Masliah E, Mallory M, Hansen L, DeTeresa R, Alford M, Terry R (1994) Synaptic and neuritic alterations during the progression of Alzheimer's disease. Neurosci Lett 174: 67-72
49. Mayer G, Nitsch R, Hoyer S (1990) Effects of changes in peripheral and cerebral glucose metabolism on locomotor activity, learning and memory in adult male rats. Brain Res 532: 95-100
50. McEwen BS (2001) Estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol 91: 2785-2801
51. Murakami Y, Tanaka E, Sakai Y, Matsumoto K, Li H-B, Watanabe H (1997) Tacrine improves working memory deficit caused by permanent occlusion of bilateral common carotid arteries in rats. Jpn J Pharmacol 75: 443-446
52. Mutisya EM, Bowling AC, Beal MF (1994) Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J Neurochem 63: 2179-2184
53. Ni J, Ohta H, Matsumoto K, Watanabe H (1994) Progressive cognitive impairment following chronic cerebral hypoperfusion induced by permanent occlusion of bilateral carotid arteries in rats. Brain Res 653: 231-236
54. Ni J, Matsumoto K, Li HB, Murakami Y, Watanabe H (1995) Neuronal damage and decrease of central acetylcholine level following permanent occlusion of bilateral common carotid arteries in rat. Brain Res 673: 290-296
55. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA (2001) Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60: 759-767
56. Ohta H, Nishikawa H, Kimura H, Anayama H, Miyamoto M (1997) Chronic cerebral hypoperfusion by permanent internal carotid ligation produces learning impairment without brain damage in rats. Neurosci 79: 1039-1050
57. Ouchi Y, Tsukada H, Kakiuchi T, Nishiyama S, Futatsubashi M (1998) Changes in cerebral blood flow and postsynaptic muscarinic cholinergic activity in rats with bilateral carotid artery ligation. J Nucl Med 39: 198-202
58. Pappas BA, de la Torre JC, Davidson CM, Keyes MT, Fortin T (1996) Chronic reduction of cerebral blood flow in the adult rat: late-emerging CA1 cell loss and memory dysfunction. Brain Res 708: 50-58
59. Piovesan P, Quatrini G, Pacifici L, Taglialatela G, Angelucci L (1995) Acetyl-L-carnitine restores choline acetyltransferase activity in the hippocampus of rats with partial unilateral fimbriafornix transection. Int J Dev Neurosci 13: 13-19
60. Plaschke K, Hoyer S (1993) Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus. Int J Dev Neurosci 11: 477-483
61. Potkin SG, Anand R, Fleming K, Alva G, Keator D, Carreon D, Messina J, Wu JC, Hartman R, Fallon JH (2001) Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease. Int J Neuropsychopharmacol 4: 223-230
62. Prickaerts J, Fahrig T, Blokland A (1999) Cognitive performance and biochemical markers in septum, hippocampus and striatum of rats after an i.c.v. injection of streptozotocin: a correlation analysis. Behav Brain Res 102: 73-88
63. Rabey JM, Sagi I, Huberman M, Melamed E, Korczyn A, Giladi N, Inzelberg R, Djaldetti R, Klein C, Berecz G (2000) Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: a double-blind study as adjunctive therapy to levodopa. Clin Neuropharmacol 23: 324-330
64. Reiter RJ, Cabrera J, Sainz RM, Mayo JC, Manchester LC, Tan DX (1999) Melatonin as a pharmacological agent against neuronal loss in experimental models of Huntington's disease, Alzheimer's disease and Parkinsonism. Ann NY Acad Sci 890: 471-485
65. 11C] methionine accumulation in probable Alzheimer's disease using positron emission tomography. J Cereb Blood Flow Metab 16: 399-408
66. Scremin OU, Scremin AME, Heuser D, Hudgell R, Romero E, Imbimbo BP (1993) Prolonged effects of cholinesterase inhibition with eptastigmine on the cerebral blood flow-metabolism ratio of normal rats. J Cereb Blood Flow Metab 13: 702-711
67. Selkoe DJ (1998) The cell biology of β-lmyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol 8: 447-453
68. Sharma M, Gupta YK (2001) Effect of chronic treatment of melatonin on learning, memory and oxidative deficiencies induced by intracerebroventricular streptozotocin in rats. Pharmacol Biochem Behav 70: 325-331
69. Sharma M, Gupta YK (2002) Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci 71: 2489-2498
70. Shi J, Perry G, Smith MA, Friedland RP (2000) Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease. Neurobiol Aging 21: 357-361
71. Simpson IA, Chundu KR, Davies-Hill T, Honer WG, Davies P (1994) Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. Ann Neurol 35: 546-551
72. Singh M, Meyer EM, Simpkins JW (1995) The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinol 136: 2320-2324
73. Small GW, Ercoli LM, Silverman DH, Huang SC, Komo S, Bookheimer SY, Lavretsky H, Miller K, Siddarth P, Rasgon NL, Mazziotta JC, Saxena S, Wu HM, Mega MS, Cummings JL, Saunders AM, Pericak-Vance MA, Roses AD, Barrio JR, Phelps ME (2000) Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci 97: 6037-6042
74. Smith KJ, Kapoor R, Felts PA (1999) Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol 9: 69-92
75. Spagnoli A, Lucca U, Menasce G, Bandera L, Cizza G, Forloni G, Tettamanti M, Frattura L, Tiraboschi P, Comelli M, Senin U, Longo A, Petrini A, Brambilla G, Belloni A, Negri C, Cavazzuti F, Salsi A, Calogero P, Parma E, Stramba-Badiale M, Vitali S, Andreoni G, Inzoli MR, Santus G, Caregnato R, Peruzza M, Favareto M, Bozeglav C, Alberoni M, De Leo D, Serraiotto L, Baiocchi A, Scoccia S, Culotta P, Ieracitano D (1991) Long-term acetyl-L-carnitine treatment in Alzheimer's disease. Neurology 41: 1726-1732
76. Svensson AL, Nordberg A (1998) Tacrine and donezepil attenuate the neurotoxic effect of A beta (25-35) in rat PC12 cells. Neuroreport 9: 1519-1522
77. Svensson AL, Nordberg A (1999) Beta-estradiol attenuate amyloid beta-peptide toxicity via nicotinic receptors. Neuroreport 10: 3485-3489
78. Taglialatela G, Navarra D, Cruciani R, Ramacci MT, Alema GS, Angelucci L (1994) Acetyl-L-carnitine treatment increases nerve growth factor levels and choline acetyltransferase activity in the central nervous system of aged rats. Exp Gerontol 29: 55-66
79. 2 generation and DNA fragmentation in pancreatic islets. Diabetes 40: 1141-1145
80. Tanaka K, Ogawa N, Asanuma M, Kondo Y, Nomura M (1996) Relationship between cholinergic dysfunction and discrimination learning disabilities in Wistar rats following chronic cerebral hypoperfusion. Brain Res 729: 55-65
81. Terwel D, Prickaerts J, Meng F, Jolles J (1995) Brain enzyme activities after intracerebroventricular injection of streptozotocin in rats receiving acetyl-L-carnitine. Eur J Pharmacol 287: 65-71
82. Tsuchiya M, Sako K, Yura S, Yonemasu Y (1993) Local cerebral glucose utilisation following acute and chronic bilateral carotid artery ligation in Wistar rats: relation to changes in local cerebral blood flow. Exp Brain Res 95: 1-7
83. Tsujimoto K, Tsuji N, Ozaki K, Minami M, Satoh M, Itoh N (1995) Expression of insulin receptor-related receptor mRNA in the rat brain is highly restricted to forebrain cholinergic neurons. Neurosci Lett 188: 105-108
84. Ueno M, Tomimoto H, Akiguchi I, Wakita H, Sakamoto H (2002) Blood-brain barrier disruption in white matter lesions in a rat model of chronic cerebral hypoperfusion. J Cereb Blood Flow Metab 22: 97-104
85. Valla J, Berndt JD, Gonzalez-Lima F (2001) Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration. J Neurosci 21: 4923-4930
86. Wakita H, Tomimoto H, Akiguchi I, Matsuo A, Lin J-X, Ihara M, McGeer PL (2002) Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat. Brain Res 924: 63-70
87. Wang LM, Han YF, Tang XC (2000) Huperzine A improves cognitive deficits caused by chronic cerebral hypoperfusion in rats. Eur J Pharmacol 398: 65-72
88. Weinstock M, Goren T, Youdim MBH (2000) Development of a novel neuroprotective drug (TV3326) for the treatment of Alzheimer's disease, with cholinesterase and monoamine oxidase inhibitory activities. Drug Dev Res 50: 216-222
89. Weinstock M, Kirschenbaum-Slager N, Lazarovici P, Bejar C, Youdim MBH, Shoham S (2001) Neuroprotective effects of novel cholinesterase inhibitors derived from rasagiline as potential anti-Alzheimer drugs. Ann NY Acad Sci 939: 148-161
90. Wilson GL, Patton NJ, McCord JM, Mullins DW, Mossman BT (1984) Mechanisms of streptozotocin and alloxan-induced damage in rat B cells. Diabetologia 27: 587-591
91. Wong TP, Debeir T, Duff K, Cuello AC (1999) Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes. J Neurosci 19: 2706-2716
92. Xiao XQ, Wang R, Han YF, Tang XC (1999) Huperazine A protects rat pheochromo-cytoma cells against hydrogen peroxide-induced injury. Neurosci Lett 275: 73-76
93. 25-35 induced oxidative injury in rat pheochromocytoma cells. Neurosci Lett 286: 155-158
94. Youdim MBH, Weinstock M (2001) Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug, TV3326, [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate]. Cell Mol Biol 21: 555-573